Clinical Trial Update: XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating oral ecnoglutide (XW004) in healthy adults to assess safety, tolerability, pharmacokinetics, and pharmacodynamics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ecnoglutide (ecnoglutide)

Snippet

Sponsor: Sciwind Biosciences APAC CO Pty. Ltd. | Conditions: Obesity, Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED